Generate Biomedicines, Inc. (GENB)

NASDAQ:GENB

US Market

GENB

Generate Biomedicines, Inc.

RESEARCH TOOLSreports

Want to see GENB full AI Analyst Report?

Generate Biomedicines, Inc. (GENB) Ownership - Who Owns Generate Biomedicines, Inc.?

18 Followers

Generate Biomedicines, Inc. (GENB) Ownership Overview

52.07% Insiders

5.30% Other Institutional Investors

0.52% ETFs

42.11% Public Companies and

Individual Investors

The ownership structure of Generate Biomedicines, Inc. (GENB) stock is a mix of institutional, retail, and individual investors. , 52.07% is owned by Insiders, and 42.11% is owned by Public Companies and Individual Investors.

The ownership structure of Generate Biomedicines, Inc. (GENB) stock is a mix of institutional, retail, and individual investors. Approximately 5.82% of the company’s stock is owned by Institutional Investors, 52.07% is owned by Insiders, and 42.11% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 06, 2026	Michael Nally	xxxxxxxxxxxxx	$240000
Mar 02, 2026	Noubar Afeyan	xxxxxxxxxxxxx	$75000000
Mar 02, 2026	Jason Silvers	xxxxxxxxxxxxx	$32000
Mar 02, 2026	Beth Grous	xxxxxxxxxxxxx	$4800

Show More Insider Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	62,673,117	Insider	48.89%	969,553,120
	2,889,154	Insider	2.25%	44,695,212
	1,184,989	Insider	0.92%	18,331,780
Cathie Wood	498,408	Institution	0.39%	7,710,372
	496,798	Institution	0.39%	7,685,465
	128,099	Institution	0.10%	1,981,692
	41,634	Institution	0.03%	644,078
	1,500	Insider	<0.01%	23,205
	1,500	Insider	<0.01%	23,205
	924	Institution	<0.01%	14,294

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
ARK Genomic Revolution ETF	474,955	Institution	0.37%	7,347,554
Vanguard Total Stock Market ETF	96,876	Institution	0.08%	1,210,950
Fidelity Nasdaq Composite Index ETF	41,634	Institution	0.03%	598,281
Vanguard Extended Market ETF	31,223	Institution	0.02%	390,288
Ark Genomic Revolution Ucits ETF AccumUSD	19,411	Institution	0.02%	300,676
-	924	Institution	<0.01%	13,278

FAQ

Who Owns Generate Biomedicines, Inc. (GENB)?

According to the latest TipRanks data, approximately 5.30% of the company's stock is held by institutional investors, 52.07% is held by insiders, and 42.11% is held by retail investors.

What percentage of Generate Biomedicines, Inc. (GENB) stock is held by institutional investors?

According to the latest TipRanks data, approximately 5.30% of Generate Biomedicines, Inc. (GENB) stock is held by institutional investors.

What percentage of Generate Biomedicines, Inc. (GENB) stock is held by retail investors?

According to the latest TipRanks data, approximately 42.11% of Generate Biomedicines, Inc. (GENB) stock is held by retail investors.

Who owns the most shares of Generate Biomedicines, Inc. (GENB)?

Noubar Afeyan owns the most shares of Generate Biomedicines, Inc. (GENB).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.